HomeMedical SpecialtiesSafe MedicationPharmacy without walls: Redefining acute care with hospital at home

Pharmacy without walls: Redefining acute care with hospital at home

Published on

Hospital at Home (HaH) at Island Health is an innovative model that delivers acute-level hospital care to patients in their homes. Developed to improve clinical outcomes, enhance patient, family caregiver, and healthcare provider experiences, and alleviate pressure on traditional hospital infrastructure, HaH reflects a strong commitment to patient-centered care. Patients and family caregivers have been involved at every stage of the program’s development and evaluation, ensuring that care delivery meets both medical and experiential needs.  The care team includes the full complement of interdisciplinary team members that are present in the brick-and-mortar hospital. Notably, over 97 per cent of patients and caregivers have reported positive experiences, highlighting the value of receiving high-quality care in the familiar setting of home.

Pharmacy services are deeply embedded in the HaH model, with clinical pharmacists contributing to care planning, Best Possible Medication History  to support medication reconciliation, and patient education. Pharmacists provide operational support and customized medication dispensing tailored to the home environment, facilitating safe and effective medication management. Their integration into the interdisciplinary team has significantly reduced drug therapy problems and enhanced continuity of care during transitions from one care environment to another. Impressively, 100 per cent of patients and caregivers surveyed recognized the essential role pharmacists played in their care.

As a learning health system, HaH engaged in quality improvement and research activities to evaluate its impact across multiple domains, including clinical outcomes, patient and family caregiver satisfaction, and staff experience. Under the leadership of Principal Investigator Dr. Sean Spina, the “Alternatives to Traditional Hospital Care Offered in Monitored Environments” (ATHOME) program team consisted of an interdisciplinary group of patient partners, academic researchers, clinicians, and program leaders.

This program contributed to the development of the model and supported Island Health’s involvement in this emerging area of care. Launched in Victoria, BC, in November 2020 as a grassroots initiative led by the Hospitalist Program with nine virtual beds, HaH has since expanded to 24 virtual beds and one other site on Vancouver Island and has served over 3,200 patients. The program combines virtual and in-person care, and patients keep the same hospital admission status as those in traditional
hospital settings. 

HaH’s success underscores the value of co-design with patients and families and shows how evidence-based, patient-oriented research can transform care delivery. International recognition of the program speaks to its global relevance and potential for scalability. As healthcare systems around the world explore sustainable, patient-centered alternatives to traditional models, HaH stands out as a blueprint for the future: personalized, responsive, and aligned with the evolving needs of communities. 

By Sean P. Spina, Tara McMillan, and Winnie Lam

Sean is the Regional Clinical Pharmacy Manager at Island Health and  leads the AT-HOME research team as Principal Investigator, evaluating the impact of Hospital at Home (HaH) models on patient care.  Tara is the Manager of Research Programs and Facilitation at Island Health and Research Manager for the AT-HOME research team. Winnie is the Pharmacy Operations Manager for the Victoria and Cowichan area hospitals within Island Health. She led the medication management portion of the HaH implementation and introduced the elastomeric IV balls for patient home use.

Latest articles

Clinical trial comparing methods of controlling bleeding in cardiac patients

Royal Columbian Hospital is one of 12 North American hospitals involved in a study...

Reducing waitlists for patients with heart valve disease

The Montreal Heart Institute recently opened the MHI’s Heart Valve Centre, a large-scale medical...

Gender bias holds back female surgeons, study finds

From ill-fitting instruments to assumptions about competence, surgical culture sidelines women, first Canadian study...

Melanoma Canada is proud to announce, the Mole Mobile.

Melanoma Canada is proud to announce, the Mole Mobile, mobile skin cancer screening unit on...

More like this

Clinical trial comparing methods of controlling bleeding in cardiac patients

Royal Columbian Hospital is one of 12 North American hospitals involved in a study...

Reducing waitlists for patients with heart valve disease

The Montreal Heart Institute recently opened the MHI’s Heart Valve Centre, a large-scale medical...

AI receptionist answers the call for busy medical clinics

Hospital patients/family members test drive AI phone software co-created by HHS doctor. A Hamilton Health...

World-first clinical trial confirms exercise improves survival for colon cancer

A groundbreaking clinical trial funded by the Canadian Cancer Society (CCS) shows that physical...

Botox at 40: From medical curiosity to a wide range of uses

Originating in a lab in San Francisco in the 1970s, botulinum toxin  –  best...

Canadian first: One-of-a-kind imaging platform for mental health

The Royal has received a $1.9 million grant from Brain Canada to launch a...